1. Growth Factor Signaling: Implications for Disease & Therapeutics

   • Shilpa Buch

   GUEST COMMENTARY 09 March 2014 Pages: 65 - 68

   

2. Targeting the PDGF Signaling Pathway in the Treatment of Non-Malignant Diseases

   • Carl-Henrik Heldin

   PERSPECTIVE 25 June 2013 Pages: 69 - 79

   

3. Implementing Neuronal Plasticity in NeuroAIDS: the Experience of Brain-derived Neurotrophic Factor and other Neurotrophic Factors

   • Italo Mocchetti
   • Alessia Bachis
   • Valeriya Avdoshina

   INVITED REVIEW 06 July 2013 Pages: 80 - 91

   

4. Fibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration

   • Maya E. Woodbury
   • Tsuneya Ikezu

   INVITED REVIEW 21 September 2013 Pages: 92 - 101

   

5. Role of Neurotrophic Factor Alterations in the Neurodegenerative Process in HIV Associated Neurocognitive Disorders

   • Jerel Fields
   • Wilmar Dumaop
   • E. Masliah

   INVITED REVIEW 08 February 2014 Pages: 102 - 116

   

6. Potential Roles of Microglial Cell Progranulin in HIV-Associated CNS Pathologies and Neurocognitive Impairment

   • Hyeon-Sook Suh
   • Benjamin B. Gelman
   • Sunhee C. Lee

   INVITED REVIEW 20 August 2013 Pages: 117 - 132

   

7. TNF-α/NF-κB Signaling in the CNS: Possible Connection to EPHB2

   • Paul D. Pozniak
   • Martyn K. White
   • Kamel Khalili

   INVITED REVIEW 27 November 2013 Pages: 133 - 141

   

8. Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation

   • S. Ramakrishnan
   • Vidhu Anand
   • Sabita Roy

   INVITED REVIEW 09 March 2014 Pages: 142 - 160

   

9. Yin and Yang of PDGF-mediated Signaling Pathway in the Context of HIV Infection and Drug Abuse

   • Honghong Yao
   • Crystal Bethel-Brown
   • Shilpa Buch

   INVITED REVIEW 20 June 2013 Pages: 161 - 167

   

10. The Roles of PDGF in Development and During Neurogenesis in the Normal and Diseased Nervous System

    • Keiko Funa
    • Masakiyo Sasahara

    INVITED REVIEW Open access 15 June 2013 Pages: 168 - 181

    

11. Neurotrophin Strategies for Neuroprotection: Are They Sufficient?

    • Joseph P. Steiner
    • Avindra Nath

    INVITED REVIEW 08 March 2014 Pages: 182 - 194

    

12. Animal Models for Depression Associated with HIV-1 Infection

    • Isabella Cristina Gomes Barreto
    • Patricia Viegas
    • Elisabete Castelon Konkiewitz

    INVITED REVIEW 12 December 2013 Pages: 195 - 208

    

13. High Fat Diet Exacerbates Neuroinflammation in an Animal Model of Multiple Sclerosis by Activation of the Renin Angiotensin System

    • Silke Timmermans
    • Jeroen F. J. Bogie
    • Jerome J. A. Hendriks

    ORIGINAL ARTICLE 26 September 2013 Pages: 209 - 217

    

14. Protection of Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease by a Physically-Modified Saline Containing Charge-Stabilized Nanobubbles

    • Saurabh Khasnavis
    • Avik Roy
    • Kalipada Pahan

    ORIGINAL ARTICLE 11 October 2013 Pages: 218 - 232

    

15. Ligand-Gated Purinergic Receptors Regulate HIV-1 Tat and Morphine Related Neurotoxicity in Primary Mouse Striatal Neuron-Glia Co-Cultures

    • Mary E. Sorrell
    • Kurt F. Hauser

    ORIGINAL ARTICLE 25 October 2013 Pages: 233 - 244

    

16. The Novel Tetramethylpyrazine Bis-nitrone (TN-2) Protects Against MPTP/MPP⁺-Induced Neurotoxicity via Inhibition of Mitochondrial-Dependent Apoptosis

    • Daping Xu
    • Hongwei Duan
    • Simon MingYuen Lee

    ORIGINAL ARTICLE 14 November 2013 Pages: 245 - 258

    

17. Platelet-Derived Growth Factor-BB Restores HIV Tat -Mediated Impairment of Neurogenesis: Role of GSK-3β/β-Catenin

    • Jie Chao
    • Lu Yang
    • Shilpa Buch

    ORIGINAL ARTICLE 19 November 2013 Pages: 259 - 268